Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
AssigneeGaneden Biotech, Inc.
InventorsSean Farmer, Andrew R. Lefkowitz
Life of this patent
Estimating the term…
Abstract
The invention relates generally to digestive disorders, and in particular to methods for treating irritable bowel syndrome by increasing carbohydrate absorption by administering a composition containing a Bacillus coagulans bacterium.
Claims18
A method of reducing a symptom of irritable bowel syndrome, improving stool consistency in a patient afflicted with non-constipated irritable bowel syndrome, decreasing urgency in a patient afflicted with irritable bowel syndrome, increasing lactose digestion, managing or increasing a subject's carbohydrate absorption, or increasing carbohydrate absorption in a subject, comprising:
- identifying a patient suffering from or at risk of developing irritable bowel syndrome, and
- administering to said patient a composition comprising Bacillus coagulans bacteria selected from the group consisting of GBI-20 (ATCC Designation Number PTA-6085), GBI-30 (ATCC Designation Number PTA-6086), and GBI-40 (ATCC Designation Number PTA-6087),
- wherein said composition further comprises a lactase, and a ratio of the lactase IU to the Bacillus coagulans bacteria is from 1:10 to 10:1, and
- wherein said symptom includes alternating diarrhea and constipation.
Dependencies are inferred from the claim text.